MODERNA Logo (WIPO, 10.06.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MODERNA wurde als Bildmarke am 10.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Linien, Bänder #Farben #Eine Linie oder ein Band #Gestrichelte Linien oder Bänder #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1551931 |
| Länder | 
|
| Basismarke |
Nr. 88929991,
22. Mai 2020
|
| Anmeldedatum | 10. Juni 2020 |
| Ablaufdatum | 10. Juni 2030 |
Markeninhaber
200 Technology Square, 2nd Floor
Cambridge MA 02139
US
Cambridge MA 02139
US
Markenvertreter
P.O. Box 1022
Minneapolis MN 55440-1022
US
Waren und Dienstleistungen
01
Biochemicals, namely, protein-encoding nucleic acids and
polypeptide-encoding nucleic acids for in vivo, ex vivo, on
vivo or in vitro scientific research and medical research,
and for use in the manufacture of food or nutritional
supplement; biochemicals, namely, protein-encoding nucleic
acids and polypeptide-encoding nucleic acids for use in the
manufacture of pharmaceuticals for treating cancers,
neurological disorders, cardiovascular disorders,
inflammatory disorders, immunoregulatory disorders,
metabolic disorders, infectious disorders, and reproductive
disorders; reagents for testing sterility of
pharmaceuticals; diagnostic reagents for scientific or
research use; chemicals for use in biotherapeutics,
biosimilars and therapeutics product development and
manufacturing processes; polypeptide encoding nucleic acids
for laboratory use
05
Medical, biological and pharmaceutical preparations for
scientific, research, medical, or pharmaceutical use,
namely, preparations for treating cancers, neurological
disorders, cardiovascular disorders, inflammatory disorders,
immunoregulatory disorders, metabolic disorders, infectious
disorders, and reproductive disorders; medical, biological
and pharmaceutical preparations containing polypeptide
encoding nucleic acids for the prevention and treatment of
rare diseases, cancers, neurological disorders,
cardiovascular disorders, inflammatory disorders,
immunoregulatory disorders, metabolic disorders, infectious
disorders and reproductive disorders; RNA-based therapeutics
and therapeutic agents for in vitro preparation and in vivo,
ex vivo, or on vivo delivery to cell sites; medical
diagnostic reagents; pharmaceuticals, namely, vaccines,
medicines, biologics, biotherapeutics, biosimilars and
therapeutics
42
Scientific research in the fields of pharmaceuticals,
vaccines, medicine, biologics, biotherapeutics, biosimilars
and therapeutics; design, engineering, research, development
and testing services in the field of protein-encoding
nucleic acids and polypeptide-encoding nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. Mai 2023 | 2023/23 Gaz | US | Korrektur |
| 29. März 2023 | 2023/16 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. März 2021 | 2021/13 Gaz | CH | Ablehnung |
| 15. Februar 2021 | 2021/7 Gaz | EM | Ablehnung |
| 10. Juni 2020 | 2020/37 Gaz | US | Eintragung |
ID: 141551931